WORTZMAN MARILYN E 4
4 · Transcept Pharmaceuticals Inc · Filed Apr 17, 2012
Insider Transaction Report
Form 4
WORTZMAN MARILYN E
VP, Finance
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2012-04-16−4,600→ 481 totalExercise: $2.12Exp: 2017-08-22→ Common Stock (4,600 underlying) - Exercise/Conversion
Common Stock
2012-04-16$2.12/sh+4,600$9,764→ 4,817 total - Sale
Common Stock
2012-04-16$11.40/sh−4,600$52,440→ 217 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 17, 2011.
- [F2]One-fourth of the shares subject to the option vested on August 22, 2008 and one forty-eighth of the shares shall vest monthly thereafter.